NCT02896335 2026-03-12Palbociclib and Pembrolizumab In Central Nervous System MetastasesMassachusetts General HospitalPhase 2 Recruiting45 enrolled
NCT04334330 2022-05-02Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in ChinaSun Yat-sen UniversityPhase 2 Unknown34 enrolled